{"id":3114,"date":"2020-11-12T12:09:00","date_gmt":"2020-11-12T12:09:00","guid":{"rendered":"https:\/\/world-heart-federation.org\/news\/wha73-statement-from-whf-and-the-global-coalition-on-covid-19-and-ncds\/"},"modified":"2022-09-05T18:14:07","modified_gmt":"2022-09-05T16:14:07","slug":"wha73-statement-from-whf-and-the-global-coalition-on-covid-19-and-ncds","status":"publish","type":"news","link":"https:\/\/world-heart-federation.org\/news\/wha73-statement-from-whf-and-the-global-coalition-on-covid-19-and-ncds\/","title":{"rendered":"WHA73: Statement from WHF and the Global Coalition on COVID-19 and NCDs"},"content":{"rendered":"

73rd<\/sup> WORLD HEALTH ASSEMBLY – Agenda Item 11.2.<\/strong><\/h2>\n

Joint Statement by the World Heart Federation and Global Coalition for Circulatory Health.<\/strong><\/h3>\n

Honorable Chair, distinguished delegates,<\/p>\n

Given the disproportionate impact of the COVID-19 pandemic on people living with NCDs and circulatory conditions such as kidney disease, diabetes, CVD<\/a>, and stroke, the International Society of Nephrology, International Diabetes Federation, World Heart Federation, and World Stroke Organization reiterate our support for Political Declaration (A73\/5) on the prevention and control of non-communicable diseases.<\/p>\n

As members of the Global Coalition for Circulatory Health, we urge you to recognize the impact of COVID-19 on patients with acute or permanent kidney failure, heart disease, and other circulatory conditions, many of whom face interruption to, or the unavailability of, life-saving treatments such as dialysis and transplantation.<\/p>\n

We would also highlight the steadily increasing prevalence of multimorbidity over the past 20 years.<\/p>\n

Kidney disease, like CVD, stroke, diabetes, and other circulatory diseases, can be triggered or worsened by other conditions, synergistically lowering the quality of life participation for the individuals affected, who also tend to have the highest rates[1]<\/a> of multimorbidity and are therefore especially vulnerable in weak health systems.<\/p>\n

Whilst multimorbidity is a growing public health concern, research into its impacts is limited due to the current lack of focus on this issue in existing global commitments.<\/p>\n

Accordingly, we call upon Member States and the WHO to:<\/p>\n